Amyloid β Peptide Other
| Cat. No. | Product Name / Activity |
|---|---|
| 5053 | AC 186 |
| Decreases Aβ levels in combination with ACP-105; ERβ agonist | |
| 1191 | Amyloid β-Peptide (1-40) (human) |
| Amyloid β-protein fragment | |
| 1428 | Amyloid β-Peptide (1-42) (human) |
| Predominant amyloid β-protein fragment | |
| 1429 | Amyloid β-peptide (25-35) (human) |
| Human amyloid β-protein fragment functionally required for neurotoxicity | |
| 0427 | Bromocriptine mesylate |
| Reduces Aβ levels; D2 and D3 receptor agonist | |
| 3945 | Colivelin |
| Neuroprotective peptide; protects against β-amyloid neurotoxicity | |
| 4803 | CRANAD 2 |
| Near-infrared probe that detects Aβ40 aggregates | |
| 5081 | J 147 |
| Neuroprotective and neurotrophic compound; reduces Aβ40 and Aβ42 levels | |
| 3144 | K 114 |
| Amyloid fibril-specific fluorescent dye | |
| 6517 | Liraglutide |
| Reduces Aβ and soluble amyloid levels in vivo; also highly potent GLP-1 receptor agonist | |
| 4920 | Methoxy-X04 |
| Fluorescent amyloid β detector; brain penetrant | |
| 7958 | QM-FN-SO3 |
| Brain penetrant, NIR aggregation-induced emission active probe for in vivo imaging of Aβ plaques | |
| 1098 | Tranilast |
| Antiallergic; binds to Aβ40 monomers | |
| 7659 | Verubecestat |
| Potently reduces Aβ formation in vitro and in vivo; BACE1 and BACE2 inhibitor |
Alzheimer's Life Science Poster
Written by Dimitra Sokolova and Soyon Hong
Our Alzheimer's disease poster summarizes the genetic, molecular and cellular changes observed in the progression of this neurodegenerative disease.
Request copyDownload PDF